OpGen Inc (OPGN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:OpGen Inc (OPGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7102
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, swift detection and analysis of antibiotic resistance, and detection of pathogens in blood cultures. OpGen’s develops products that includes QuickFISH, and PNA FISH products, Acuitas products, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.

OpGen Inc (OPGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OpGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OpGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
OpGen Inc, Medical Equipment, Deal Details 12
Venture Financing 12
AdvanDx Raises USD2.5 Million in Venture Financing 12
OpGen Raises USD1.2 Million in Venture Financing 13
Opgen Raises USD1 Million in Venture Financing 14
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 15
OpGen Raises US$2 Million In Venture Financing 16
AdvanDx Raises US$2 Million In Venture Financing 17
OpGen Raises Additional US$2.6 Million In Series C Financing 18
OpGen Raises Additional USD1.4 Million in Venture Financing 20
Partnerships 21
OpGen Enters into Research Agreement with Merck 21
OpGen Enters into Co-Development Agreement with Fluidigm 22
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 23
OpGen Enters Into Co-Development Agreement With In-Q-Tel 24
Equity Offering 25
OpGen Raises USD12 Million in Public Offering of Units 25
Opgen Raises USD10 Million in Public Offering of Units 27
OpGen to Raise upto USD11.5 Million in Public Offering of Shares 28
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 29
OpGen Raises USD17 Million in IPO 31
Debt Offering 33
OpGen Raises USD0.5 Million in Debt Financing 33
OpGen Raises USD1.5 Million in Private Placement of 8% Notes 34
Acquisition 35
OpGen Acquires AdvanDx 35
OpGen Inc – Key Competitors 36
OpGen Inc – Key Employees 37
OpGen Inc – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Financial Announcements 39
Aug 02, 2018: Opgen announces second quarter 2018 financial results 39
May 08, 2018: OpGen Announces First Quarter 2018 Financial Results 41
Mar 15, 2018: OpGen Announces Fourth Quarter and Full Year 2017 Financial Results 43
Nov 07, 2017: OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update 45
Aug 08, 2017: OpGen Reports 2017 Second Quarter Financial Results and Provides Business Update 47
Apr 26, 2017: OpGen Announces 2017 First Quarter Financial Results 49
Mar 23, 2017: OpGen Announces 2016 Fourth Quarter and Year End Financial Results 50
Jan 26, 2017: OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial Results 51
Corporate Communications 53
Apr 27, 2017: OpGen Appoints Tina S. Nova, Ph.D. to Board of Directors 53
Legal and Regulatory 54
Feb 05, 2018: OpGen Regains Compliance With Nasdaq Listing Requirements 54
Product News 55
Feb 01, 2018: OpGen Introduces New RUO Rapid Test for Infection Control and Surveillance Studies 55
Apr 12, 2017: OpGen to Present Antibiotic Resistance Prediction Data at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 56
Feb 14, 2017: OpGen Presents Rapid Acuitas Genetic Test Data at Advances in Genome Biology and Technology Meeting 58
Other Significant Developments 59
Mar 13, 2018: OpGen Announces Collaborator in Verification Study for Acuitas Test 59
Feb 13, 2018: OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas Tests 60
Jun 15, 2017: OpGen’s Acuitas Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
OpGen Inc, Medical Equipment, Key Facts, 2017 2
OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OpGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OpGen Inc, Deals By Market, 2012 to YTD 2018 9
OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
AdvanDx Raises USD2.5 Million in Venture Financing 12
OpGen Raises USD1.2 Million in Venture Financing 13
Opgen Raises USD1 Million in Venture Financing 14
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 15
OpGen Raises US$2 Million In Venture Financing 16
AdvanDx Raises US$2 Million In Venture Financing 17
OpGen Raises Additional US$2.6 Million In Series C Financing 18
OpGen Raises Additional USD1.4 Million in Venture Financing 20
OpGen Enters into Research Agreement with Merck 21
OpGen Enters into Co-Development Agreement with Fluidigm 22
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 23
OpGen Enters Into Co-Development Agreement With In-Q-Tel 24
OpGen Raises USD12 Million in Public Offering of Units 25
Opgen Raises USD10 Million in Public Offering of Units 27
OpGen to Raise upto USD11.5 Million in Public Offering of Shares 28
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 29
OpGen Raises USD17 Million in IPO 31
OpGen Raises USD0.5 Million in Debt Financing 33
OpGen Raises USD1.5 Million in Private Placement of 8% Notes 34
OpGen Acquires AdvanDx 35
OpGen Inc, Key Competitors 36
OpGen Inc, Key Employees 37
OpGen Inc, Subsidiaries 38

List of Figures
OpGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OpGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OpGen Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[OpGen Inc (OPGN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brighthouse Financial, Inc. (BHF):企業の財務・戦略的SWOT分析
    Brighthouse Financial, Inc. (BHF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Moody’s Corporation:企業のM&A・事業提携・投資動向
    Moody's Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moody's Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Sega Sammy Holdings Inc (6460):企業の財務・戦略的SWOT分析
    Sega Sammy Holdings Inc (6460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Cook Medical Inc:企業の戦略的SWOT分析
    Cook Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Enterome Bioscience SA-製薬・医療分野:企業M&A・提携分析
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …
  • SMBC Trust Bank Private Banking:企業の戦略・SWOT・財務情報
    SMBC Trust Bank Private Banking - Strategy, SWOT and Corporate Finance Report Summary SMBC Trust Bank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Grupo Ferrer Internacional SA:企業の戦略・SWOT・財務情報
    Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • AFFiRiS AG-製薬・医療分野:企業M&A・提携分析
    Summary Affiris AG (AFFiRiS) is a drug development company that develops and manufactures novel synthetic vaccines against chronic diseases. The company develops customized peptide vaccines based on its proprietary affitome technology for the prevention of Alzheimer's disease, Parkinson's disease, a …
  • Kareo Inc:医療機器:M&Aディール及び事業提携情報
    Summary Kareo Inc (Kareo) provides a cloud-based medical technology platform that meets the needs of healthcare providers. The company offers cloud-based electronic health records (EHR) that helps clinicians to manage the care of the patients and record or access required information at the point of …
  • Bord na Mona Plc:企業の戦略的SWOT分析
    Bord na Mona Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Daybreak Oil and Gas Inc (DBRM):石油・ガス:M&Aディール及び事業提携情報
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • Japan Airlines Co Ltd:企業の戦略・SWOT・財務分析
    Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Xintela AB (XINT):企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also o …
  • Alion Science and Technology Corporation:企業の戦略・SWOT・財務情報
    Alion Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Alion Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • First Solar, Inc.:企業のM&A・事業提携・投資動向
    First Solar, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Solar, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Case Western Reserve University-製薬・医療分野:企業M&A・提携分析
    Summary Case Western Reserve University (CWRU) is a private research university that offers educational and research programs. The institute provides bachelor, master’s, doctoral and research programs through its colleges and professional schools, besides postdoctoral training. It offers courses in …
  • Prothena Corp Plc (PRTA)-製薬・医療分野:企業M&A・提携分析
    Summary Prothena Corp Plc (Prothena) is a biotechnology company that discovers, develops and markets novel antibodies that are indicated for the treatment of diseases associated with amyloid or cell adhesion. The company develops monoclonal antibodies directed specifically at disease-causing protein …
  • EVN AG (EVN)-エネルギー分野:企業M&A・提携分析
    Summary EVN AG (EVN) is an energy and environmental services company. It provides electricity, natural gas, heat, drinking water, wastewater treatment, thermal waste utilization, and related services. The company produces power from thermal and renewable sources. EVN procures electricity, natural ga …
  • Imvescor Restaurant Group Inc:戦略・SWOT・企業財務分析
    Imvescor Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report Summary Imvescor Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Aspyrian Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aspyrian Therapeutics Inc (Aspyrian Therapeutics) is a biotechnology company which develops precision targeted medicines to handle both the primary tumor and systemic disease. Its lead pipeline product, RM-1929, is under development for the treatment of different cancer types, including canc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆